291 results on '"Roybon, Laurent"'
Search Results
2. Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson’s disease related transcriptional profile and function
3. Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
4. Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome
5. Cellular Aging Secretes: a Comparison of Bone-Marrow-Derived and Induced Mesenchymal Stem Cells and Their Secretome Over Long-Term Culture
6. The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregation
7. Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration.
8. TNFa hinders FGF4 efficacy to mitigate ALS astrocyte dysfunction and cGAS-STING pathway-induced innate immune reactivity
9. Inhibition of the serine protease HtrA1 by SerpinE2 suggests a role for an extracellular proteolytic pathway in the control of neural crest migration
10. Inhibition of the serine protease HtrA1 by SerpinE2 suggests an extracellular proteolytic pathway in the control of neural crest migration
11. Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition
12. Parkin absence accelerates microtubule aging in dopaminergic neurons
13. Differential alteration of hippocampal function and plasticity in females and males of the APPxPS1 mouse model of Alzheimer's disease
14. Cellular alterations identified in pluripotent stem cell-derived midbrain spheroids generated from a female patient with progressive external ophthalmoplegia and parkinsonism who carries a novel variation (p.Q811R) in the POLG1 gene
15. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies
16. FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
17. Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer’s disease pathogenesis
18. Memory formation orchestrates the wiring of adult-born hippocampal neurons into brain circuits
19. Cellular Aging Secretes: a Comparison of Bone-Marrow-Derived and Induced Mesenchymal Stem Cells and Their Secretome Over Long-Term Culture
20. Developing Novel Cell Sources for Transplantation in Parkinson’s Disease
21. Parkinsons disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties
22. Canonical Bone Morphogenetic Protein Signaling Regulates Expression of Aquaporin-4 and Its Anchoring Complex in Mouse Astrocytes
23. Parkinson’s disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein–induced changes in maturation and immune reactive properties
24. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats
25. α-Synuclein is a Novel Microtubule Dynamase
26. Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient
27. Human iPSC-derived hippocampal spheroids: An innovative tool for stratifying Alzheimer disease patient-specific cellular phenotypes and developing therapies
28. Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer’s disease
29. TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
30. Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome
31. Accelerated High-Yield Generation of Limb-Innervating Motor Neurons from Human Stem Cells v1
32. Generation of the Human Pluripotent Stem-Cell-Derived Astrocyte Model with Forebrain Identity
33. Stem cell therapy for Parkinson’s disease: where do we stand?
34. Unique signatures of stress-induced senescent human astrocytes
35. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies
36. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson’s disease
37. Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene
38. GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2
39. Absence of striatal newborn neurons with mature phenotype following defined striatal and cortical excitotoxic brain injuries
40. Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis
41. Emerging restorative treatments for Parkinsonʼs disease
42. Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes
43. PARK2 Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons
44. NF‐E2‐related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin‐1 mutated Alzheimer's disease astrocytes
45. PARK2 Mutation Causes Metabolic Disturbances and Impaired Survival of Human iPSC-Derived Neurons
46. Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
47. Human Astrocytes Transfer Aggregated Alpha-Synuclein via Tunneling Nanotubes
48. NF‐E2‐related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin‐1 mutated Alzheimer's disease astrocytes.
49. Generation of an induced pluripotent stem cell line (CSC-41) from a Parkinson's disease patient carrying a p.G2019S mutation in the LRRK2 gene
50. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.